The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 23rd 2024
The approval was based on the QUILT-3.032 study, which included 77 adults with carcinoma in situ with or without papillary tumors after a transurethral resection.
FDA Approves IgG-Hyaluronidase Recombinant for the Treatment of Adult Patients With CIDP
January 16th 2024Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.
Read More
Guideline Update: KDIGO 2024 Management of Lupus Nephritis Includes Belimumab for Triple Therapy
January 11th 2024The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.
Read More